You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CADL Sale Disclosure
Barone Francesca · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$235.77K
Barone Francesca Chief Scientific Officer
CADL
Candel Therapeutics
CADL
Transaction date
Jun 29, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 2 days later
CADL daily price context
Close on/before transaction
$10.36
Jun 29, 2026
First close after public filing
$9.83
Jul 2, 2026
30-day return after filing
+1.83%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 23,447 shares @ $10.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001909680-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$235.77K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Candel Therapeutics, Inc. CADL Current | Sale | Jun 29, 2026 | $235.77K |